Servier CDMO offers a variety of tableting and encapsulation options to optimize your product’s therapeutic performance. Our tablet capabilities range from immediate, controlled and modified release to film and sugar coating, and we have the equipment and expertise to encapsulate powders, granules and micro-tablets.
Servier CDMO has high-performance production capabilities for a full range of dosage forms and product groups, including liquids, sprays and powders. Our manufacturing and packaging suites have separate air handling and filtration systems to ensure full quality control and assurance across the lifecycle of your product.
Servier CDMO provides custom manufacturing of APIs and HPAPIs from worldwide facilities. Our industry-leading methodologies, combined with state-of-the-art containment tools, enables us to handle your project from development through commercial phases, addressing any technical and regulatory challenges that may arise.
We manufacture pharmaceutical intermediates from state-of-the-art cGMP and FDA-approved chemical facilities around the world. Leveraging our integrated network of R&D, production and supply chain expertise, we provide intermediate manufacturing for both GMP and non-GMP requirements, from kilogram scale to several metric tons.
At Servier CDMO, we provide a number of cost-effective primary and secondary packaging options, including blisters, sachets and bottles. We strictly adhere to global standards for serialization and aggregation, and provide tamper-evident packaging and labeling in line with EU requirements.
One of Servier’s two cGMP chemical production sites, our Oril Industrie facility in the Normandy region of France specializes in the development and manufacture of intermediates, APIs and HPAPIs for worldwide distribution. It is also the epicenter for our Innoprep™ industrial-scale preparative chromatography.
Servier’s Oril Industrie facility in Bolbec specializes in the development and manufacture of intermediates, APIs and HPAPIs for worldwide distribution.
With reduced purification times, higher target molecule purities and the ability to quickly separate and identify impurities, preparative chromatography can provide a greater understanding of products and processes while reducing time to the clinic and the market.
Paris, France, October 1, 2018 – Servier, an independent international pharmaceutical company, today announced the launch of InnoPreP™ – a new preparative chromatography service offered under its contract development and manufacturing business.